JP2024514830A5 - - Google Patents
Info
- Publication number
- JP2024514830A5 JP2024514830A5 JP2023561752A JP2023561752A JP2024514830A5 JP 2024514830 A5 JP2024514830 A5 JP 2024514830A5 JP 2023561752 A JP2023561752 A JP 2023561752A JP 2023561752 A JP2023561752 A JP 2023561752A JP 2024514830 A5 JP2024514830 A5 JP 2024514830A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163170976P | 2021-04-05 | 2021-04-05 | |
| US63/170,976 | 2021-04-05 | ||
| PCT/EP2022/059031 WO2022214499A2 (en) | 2021-04-05 | 2022-04-05 | Diagnosis and treatment of myeloid disorders and acute leukemias using novel tumor specific antigenscross-reference to related applications |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024514830A JP2024514830A (ja) | 2024-04-03 |
| JPWO2022214499A5 JPWO2022214499A5 (https=) | 2025-04-15 |
| JP2024514830A5 true JP2024514830A5 (https=) | 2025-04-15 |
Family
ID=81307292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023561752A Pending JP2024514830A (ja) | 2021-04-05 | 2022-04-05 | 新規腫瘍特異的抗原を使用する骨髄性障害および急性白血病の診断および処置 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240180963A1 (https=) |
| EP (1) | EP4320154A2 (https=) |
| JP (1) | JP2024514830A (https=) |
| KR (1) | KR20240027578A (https=) |
| CN (1) | CN117881700A (https=) |
| AU (1) | AU2022255573A1 (https=) |
| CA (1) | CA3216175A1 (https=) |
| IL (1) | IL307498A (https=) |
| MX (1) | MX2023011766A (https=) |
| WO (1) | WO2022214499A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3255414A1 (en) * | 2022-04-05 | 2023-10-12 | Alhena Science S.R.L. | TREATMENT FOR MYELOID DISORDERS AND ACUTE LEUKEMIAS TARGETING NEW TUMOR-SPECIFIC ANTIGENS |
| WO2025113635A1 (zh) * | 2023-12-01 | 2025-06-05 | 上海祥耀生物科技有限责任公司 | 抗cd84抗体及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US7361343B2 (en) * | 2003-01-21 | 2008-04-22 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| US7361342B2 (en) * | 2003-01-21 | 2008-04-22 | Arius Research Inc. | Cancerous disease modifying antibodies |
| US7750116B1 (en) | 2006-02-18 | 2010-07-06 | Seattle Genetics, Inc. | Antibody drug conjugate metabolites |
| ES2800328T3 (es) * | 2008-09-23 | 2020-12-29 | Yeda Res And Development Company Ltd | Métodos para diagnosticar y tratar la leucemia linfocítica crónica de linfocitos B en base a la detección e inhibición de CD84 |
| MX379256B (es) | 2013-03-15 | 2025-03-10 | Regeneron Pharma | Moleculas biologicamente activas, conjugados de las mismas, y usos terapeuticos. |
| ES3063961T3 (en) * | 2014-02-14 | 2026-04-21 | Cellectis | Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells |
| JP2019505511A (ja) * | 2016-01-06 | 2019-02-28 | イェダ リサーチ アンド ディベロップメント カンパニー リミテッドＹｅｄａ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｄｅｖｅｌｏｐｍｅｎｔ Ｃｏ．Ｌｔｄ． | 悪性疾患、自己免疫疾患および炎症性疾患を処置するための組成物および方法 |
| WO2018002902A1 (en) | 2016-07-01 | 2018-01-04 | Glaxosmithkline Intellectual Property (No.2) Limited | Antibody-drug conjugates and therapeutic methods using the same |
| US12534532B2 (en) * | 2018-10-26 | 2026-01-27 | Crage Medical Co., Limited | CLL1-targeting antibody and application thereof |
-
2022
- 2022-04-05 US US18/285,850 patent/US20240180963A1/en active Pending
- 2022-04-05 IL IL307498A patent/IL307498A/en unknown
- 2022-04-05 JP JP2023561752A patent/JP2024514830A/ja active Pending
- 2022-04-05 EP EP22716261.7A patent/EP4320154A2/en active Pending
- 2022-04-05 KR KR1020237038027A patent/KR20240027578A/ko active Pending
- 2022-04-05 CA CA3216175A patent/CA3216175A1/en active Pending
- 2022-04-05 MX MX2023011766A patent/MX2023011766A/es unknown
- 2022-04-05 WO PCT/EP2022/059031 patent/WO2022214499A2/en not_active Ceased
- 2022-04-05 AU AU2022255573A patent/AU2022255573A1/en active Pending
- 2022-04-05 CN CN202280040186.6A patent/CN117881700A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025511758A5 (https=) | ||
| JP2024514830A5 (https=) | ||
| CL2025003823A1 (es) | Proceso para la extracción de magnesio metálico de fuentes de minerales. | |
| BR102023014872A2 (https=) | ||
| BR102023005164A2 (https=) | ||
| BR102023001877A2 (https=) | ||
| BR202022009269U2 (https=) | ||
| BR202022001779U2 (https=) | ||
| BR202022000931U2 (https=) | ||
| BY13140U (https=) | ||
| CN307047345S (https=) | ||
| BY13158U (https=) | ||
| BY13157U (https=) | ||
| BY13156U (https=) | ||
| BY13155U (https=) | ||
| BY13153U (https=) | ||
| BY13152U (https=) | ||
| BY13151U (https=) | ||
| BY13150U (https=) | ||
| BY13145U (https=) | ||
| BY13144U (https=) | ||
| BY13143U (https=) | ||
| BY13141U (https=) | ||
| CN307049536S (https=) | ||
| BY13159U (https=) |